ASR™ Hip System Recall Guide
DePuy Orthopaedics, Inc.(DePuy) has recalled the ASR XL Acetabular Hip System and DePuy ASR ARTICULAR SURFACE REPLACEMENT® Hip Resurfacing System (ASR).
Your patients will have questions, and our goal with this guide is to help you answer their questions and to support your evaluation and continued care of them.
Patients who had hip surgery prior to July 2003 are not subject to this recall.
To register a patient for treatment, call the ASR Help Line on 1800 665 460. The Call Centre will be active from 8.30 am – 5.00 pm, Monday through Friday AEST.
call us for assistance
The following physicians are available to answer clinical questions:
Dr Leanne Wall Medical Affairs Director ANZ
+61 2 9815 3661
Dr Kanwarjit Singh, VP, Medical & Clinical Affairs and Development
+65 6827 6074
DePuy makes patient safety and health a top priority and is continually evaluating data about its products. The ASR™ Hip is one of many hip implants available from DePuy. Most ASR hip replacement surgeries have been successful. However, data recently received by the company shows that more people than expected who received the ASR Hip System experienced pain and other symptoms that led them to have a second hip replacement surgery, called a revision surgery. The 2010 Australian National Joint Replacement Registry reports five years after having an ASR hip implanted 7.8% of patients (1 in 13) who had an ASR total hip replacement and 10.9% of patients (1 in 10) who had the ASR resurfacing device needed to have revision surgery. British data shows that five years after having the hip implanted, approximately 12% of patients (1 in 8) who had received the ASR resurfacing device and 13% of patients (1 in 8) who had received the ASR total hip replacement needed to have a revision surgery. We appreciate your assistance in providing ASR hip implant recipients and your organisation with important information about this recall.
Country Region:
Do not include in the landing page
